Product Name :URAD polyclonal antibody
Application_all :WB (1/500 - 1/1000)
Background :Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase: Catalyzes the stereoselective decarboxylation of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) to (S)-allantoin, a step in the uric acid degradation pathway following urate oxidation (By similarity). In humans, the protein appears to be poorly or not expressed, suggesting that this activity is likely not operative (Probable)
Product :1mg/ml in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Purification&Purity :The antibody was purified by immunogen affinity chromatography.
Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :Recognizes endogenous levels of URAD protein
Note :For research use only, not for use in diagnostic procedure.
Alternative Name :PRHOXNB; Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase; OHCU decarboxylase; Parahox neighbor; Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase
Immunogen :A synthetic peptide encompassing a sequence within the center region of human URAD.
Modification :Unmodification
